VUMedicalCentre
Amsterdam, North Holland, 1007 MB, Netherlands
NCT Number: NCT02666937
A study consisting of a prospective and retrospective cohort in the ICU, ER and pulmonary department in a university hospital in Amsterdam and a teaching hospital in Alkmaar, the Netherlands.
The relationship between the oxygen saturation measured by pulse-oximetry and the arterial PaO2 is investigated in order to investigate which transcutaneous saturation values are safe when administering oxygen in relation to hyperopia and hypoxia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Amsterdam, North Holland, 1007 MB, Netherlands
This study consists of two parts a prospective and a retrospective part.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for all inclusions:
Exclusion criteria
for all inclusions:
Additional inclusion criteria:
Additional exclusion criteria:
Time frame: Average of one week
To determine peripherally measured saturation targets between which no hyperoxia and hypoxia will occur
Time frame: Average of one week
To identify factors influencing the relationship between SpO2 and PaO2, such as hemodynamics, peripheral circulation, shock and pH
Time frame: Average of one week
To determine differences in the SpO2/PaO2 -relationship in different populations
Time frame: Average of one week
To determine differences in the SpO2/PaO2 -relationship in a prospective and a retrospective cohort
Amsterdam UMC, location VUmc
Other
Acronym: SLIM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06374225
Burns, Critical Illness
Aurora, Colorado, United States
View Trial DetailsNCT03789396
Critical Illness, Disease Attributes
Aurora, Colorado, United States
View Trial DetailsNCT06692400
Adult, Biomarkers / Blood
Loma Linda, California, United States
View Trial DetailsNCT05883137
Critical Illness, Disease Attributes
Stockholm, Stockholm County, Sweden
View Trial Details